Covidien Introduces New Surgical Access Devices at SAGES 2013

  Covidien Introduces New Surgical Access Devices at SAGES 2013

     Company enters wound protector market with new SurgiSleeve™; Expands
                Versaport™ bladeless optical trocar portfolio

Business Wire

BALTIMORE -- April 17, 2013

Covidien (NYSE: COV), a leading global provider of healthcare products, is
launching two new surgical access devices at the annual meeting of the Society
of American Gastrointestinal and Endoscopic Surgeons (SAGES), which starts
today. At the meeting, the Company also plans to conduct a number of hands-on
labs to showcase innovative surgical solutions that address unmet clinical
needs in bariatric, colorectal, hernia, endoluminal and other procedures.

The SurgiSleeve(TM) wound protector is easy to place, and since the material
is three times stronger ...

The SurgiSleeve(TM) wound protector is easy to place, and since the material
is three times stronger on average than what is used in the leading
competitive product, the likelihood of tearing during a procedure is reduced.
(Photo: Business Wire)

Covidien enters the fast-growing wound protector market with the global launch
of SurgiSleeve™. Used in both open and minimally invasive surgery, the new
access device protects the wound site from contamination and also provides
excellent exposure and visualization. The SurgiSleeve wound protector is easy
to place, and since the material is three times stronger on average than what
is used in the leading competitive product^1, the likelihood of tearing during
a procedure is reduced.

The introduction of the Versaport™ Bladeless Optical 12 mm Trocar is the
newest addition to the wide offering of Covidien access products. It offers
surgeons visualization during trocar placement to help clinicians minimize the
risk of trocar injuries. It shares the same proprietary cannula design as the
rest of Covidien’s optical and bladeless trocar family, offering excellent
fixation for port security and stability.

“Collaborating with the global surgical community, we continue to expand and
complement our extensive product portfolio. We are focused on delivering high
quality, high value solutions that meet both clinical and economic needs,”
said Steve Blazejewski, President, Surgical Supplies, Covidien.

In addition to the new SurgiSleeve and Versaport devices, Covidien is
showcasing the latest enhancements to many of its most impactful innovations,
including the Sonicision™ cordless ultrasonic device, iDrive™ Ultra powered
stapling system, Endo GIA™ Tri-Staple™ technology platform, LigaSure™
portfolio, V-Loc™ Wound Closure reload, Barrx™ ablation system, AbsorbaTack™,
Parietex™ and ProGrip™ portfolios. For more information, please visit SAGES
Booth #211.

About Covidien

Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in three
segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012
revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70
countries, and its products are sold in over 140 countries. Please visit
www.covidien.com to learn more about our business.

1. Comparison of mean strengths between SurgiSleeve™ wound protector and
Alexis® wound protector as part of a February 9, 2012 Puncture Resistance
Material Evaluation (Report # 2151-002; report on file). Statistically
significant P value is 0.004.

Alexis is a registered trademark of Applied Medical Resources Corporation

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130417005387/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50611361&lang=en

Contact:

Covidien
John Jordan, 508-452-4891
Manager, Communications
john.jordan@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President, Investor Relations
cole.lannum@covidien.com
or
Marguerite Copel, 203-821-4720
Vice President, Communications
marguerite.copel@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director, Investor Relations
todd.carpenter@covidien.com
 
Press spacebar to pause and continue. Press esc to stop.